153
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Application of Single Nucleotide Polymorphism Microarray in Prenatal Diagnosis of Fetuses with Central Nervous System Abnormalities

ORCID Icon, , , , , & ORCID Icon show all
Pages 4239-4246 | Published online: 06 Aug 2021

References

  • Van den Veyver IB. Prenatally diagnosed developmental abnormalities of the central nervous system and genetic syndromes: a practical review. Prenat Diagn. 2019;39(9):666–678. doi:10.1002/pd.5520
  • Onkar D, Onkar P, Mitra K. Evaluation of fetal central nervous system anomalies by ultrasound and its anatomical co-relation. J Clin Diagn Res. 2014;8(6):AC05–07.
  • Sun L, Wu Q, Jiang SW, et al. Prenatal diagnosis of central nervous system anomalies by high-resolution chromosomal microarray analysis. Biomed Res Int. 2015;2015:426379. doi:10.1155/2015/426379
  • Huang J, Wah IY, Pooh RK, Choy KW. Molecular genetics in fetal neurology. Semin Fetal Neonatal Med. 2012;17(6):341–346. doi:10.1016/j.siny.2012.07.007
  • Hof MCVD, Wilson RD. Fetal soft markers in obstetric ultrasound. J Obstet Gynaecol Ca. 2005;27(6):592–636.
  • Schaaf CP, Wiszniewska J, Beaudet AL. Copy number and SNP arrays in clinical diagnostics. Annu Rev Genomics Hum Genet. 2011;12:25–51. doi:10.1146/annurev-genom-092010-110715
  • Reddy UM, Page GP, Saade GR, et al. Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med. 2012;367(23):2185–2193. doi:10.1056/NEJMoa1201569
  • Engels H, Brockschmidt A, Hoischen A, et al. DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation. Neurology. 2007;68(10):743–750. doi:10.1212/01.wnl.0000256367.70365.e0
  • Stankiewicz P, Beaudet AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev. 2007;17(3):182–192. doi:10.1016/j.gde.2007.04.009
  • Vissers LE, de Vries BB, Veltman JA. Genomic microarrays in mental retardation: from copy number variation to gene, from research to diagnosis. J Med Genet. 2010;47(5):289–297. doi:10.1136/jmg.2009.072942
  • Vissers LE, Veltman JA, van Kessel AG, Brunner HG. Identification of disease genes by whole genome CGH arrays. Hum Mol Genet. 2005;14(2):R215–223. doi:10.1093/hmg/ddi268
  • Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–2184. doi:10.1056/NEJMoa1203382
  • Liao C, Fu F, Li R, et al. Implementation of high-resolution SNP arrays in the investigation of fetuses with ultrasound malformations: 5 years of clinical experience. Clin Genet. 2014;86(3):264–269. doi:10.1111/cge.12271
  • Charan P, Woodrow N, Walker SP, Ganesamoorthy D, McGillivray G, Palma-Dias R. High-resolution microarray in the assessment of fetal anomalies detected by ultrasound. Aust N Z J Obstet Gynaecol. 2014;54(1):46–52. doi:10.1111/ajo.12170
  • Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–764. doi:10.1016/j.ajhg.2010.04.006
  • American College of O, Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110(6):1459–1467. doi:10.1097/01.AOG.0000291570.63450.44
  • Bian X. Practical Prenatal Diagnosis. Beijing: People’s Military Medical Press; 2008.
  • International Standing Committee on Human Cytogenomic Nomenclature. McGowan-Jordan J, Simons A, Schmid M. ISCN: An International System for Human Cytogenomic Nomenclature (2016). Basel, New York: Karger; 2016.
  • Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST; Working Group of the American College of Medical Genetics Laboratory Quality Assurance C. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680–685. doi:10.1097/GIM.0b013e3182217a3a
  • Petracchi F, Crespo L, Michia C, Igarzabal L, Gadow E. Holoprosencephaly at prenatal diagnosis: analysis of 28 cases regarding etiopathogenic diagnoses. Prenat Diagn. 2011;31(9):887–891.
  • Lehman CD, Nyberg DA, Winter TC, Kapur RP, Resta RG, Luthy DA. Trisomy 13 syndrome: prenatal US findings in a review of 33 cases. Radiology. 1995;194(1):217–222. doi:10.1148/radiology.194.1.7997556
  • Gezer C, Ekin A, Ozeren M, et al. Chromosome abnormality incidence in fetuses with cerebral ventriculomegaly. J Obstet Gynaecol. 2014;34(5):387–391. doi:10.3109/01443615.2014.896885
  • Hayashi Y, Suzumori N, Sugiura T, Sugiura-Ogasawara M. Prenatal findings of holoprosencephaly. Congenit Anom (Kyoto). 2015;55(3):161–163. doi:10.1111/cga.12103
  • Tang XH, Yang BC, Zhu S, et al. Prenatal diagnosis of chromosome abnormalities and nine microdeletion syndromes using both traditional karyotyping and BoBs. Chin J Obstet Gynecol. 2016;51(5):325–330.
  • D’Amours G, Kibar Z, Mathonnet G, et al. Whole-genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype. Clin Genet. 2012;81(2):128–141. doi:10.1111/j.1399-0004.2011.01687.x
  • Hillman SC, Pretlove S, Coomarasamy A, et al. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obst Gyn. 2011;37(1):6–14. doi:10.1002/uog.7754
  • Paulussen AD, Schrander-Stumpel CT, Tserpelis DC, et al. The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes. Eur J Hum Genet. 2010;18(9):999–1005. doi:10.1038/ejhg.2010.70
  • Litwack ED, Babey R, Buser R, Gesemann M, O’Leary DD. Identification and characterization of two novel brain-derived immunoglobulin superfamily members with a unique structural organization. Mol Cell Neurosci. 2004;25(2):263–274. doi:10.1016/j.mcn.2003.10.016
  • Hanson E, Bernier R, Porche K, et al. The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population. Biol Psychiatry. 2015;77(9):785–793. doi:10.1016/j.biopsych.2014.04.021
  • Rosenfeld JA, Coppinger J, Bejjani BA, et al. Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications. J Neurodev Disord. 2010;2(1):26–38. doi:10.1007/s11689-009-9037-4
  • Martin-Brevet S, Rodriguez-Herreros B, Nielsen JA, et al. Quantifying the effects of 16p11.2 copy number variants on brain structure: a multisite genetic-first study. Biol Psychiatry. 2018;84(4):253–264. doi:10.1016/j.biopsych.2018.02.1176
  • Song T, Xu Y, Li Y, et al. Detection of submicroscopic chromosomal aberrations by chromosomal microarray analysis for the prenatal diagnosis of central nervous system abnormalities. J Clin Lab Anal. 2020;34(10):e23434. doi:10.1002/jcla.23434